Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

Detalles Bibliográficos
Autores principales: Sangroongruangsri, Sermsiri, Chaikledkaew, Usa, Kumluang, Suthasinee, Wu, Olivia, Geue, Claudia, Ratanapakorn, Tanapat, Leelahavarong, Pattara, Ingsrisawang, Lily, Ruamviboonsuk, Paisan, Taweebanjongsin, Wongsiri, Choovuthayakorn, Janejit, Singalavanija, Apichart, Hanutsaha, Prut, Kulvichit, Kittisak, Ratanapojnard, Thitiporn, Wongsawad, Warapat, Teerawattananon, Yot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827997/
https://www.ncbi.nlm.nih.gov/pubmed/30659496
http://dx.doi.org/10.1007/s40261-019-00747-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827997/
https://www.ncbi.nlm.nih.gov/pubmed/30659496
http://dx.doi.org/10.1007/s40261-019-00747-y

Ejemplares similares